Liver stiffness diminishes with antiviral response in chronic hepatitis C
Hézode, C., Castéra, L., Roudot‐Thoraval, F., Bouvier‐Alias, M., Rosa, I., Roulot, D., Leroy, V., Mallat, A., Pawlotsky, J.‐M.
Published in Alimentary pharmacology & therapeutics (01.09.2011)
Published in Alimentary pharmacology & therapeutics (01.09.2011)
Get full text
Journal Article
Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care
Chevaliez, S., Poiteau, L., Rosa, I., Soulier, A., Roudot-Thoraval, F., Laperche, S., Hézode, C., Pawlotsky, J.-M.
Published in Clinical microbiology and infection (01.05.2016)
Published in Clinical microbiology and infection (01.05.2016)
Get full text
Journal Article
Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots
Poiteau, L., Soulier, A., Rosa, I., Roudot-Thoraval, F., Hézode, C., Pawlotsky, J.-M., Chevaliez, S.
Published in Journal of viral hepatitis (01.05.2016)
Published in Journal of viral hepatitis (01.05.2016)
Get full text
Journal Article
Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor
Fourati, S., Guedj, J., Chevaliez, S., Nguyen, T. H. T., Roudot‐Thoraval, F., Ruiz, I., Soulier, A., Scoazec, G., Varaut, A., Poiteau, L., Francois, M., Mallat, A., Hézode, C., Pawlotsky, J.‐M.
Published in Alimentary pharmacology & therapeutics (01.03.2018)
Published in Alimentary pharmacology & therapeutics (01.03.2018)
Get full text
Journal Article
OP0235 Interferon-free antivirals for hepatitis c virus-associated cryoglobulinemia vasculitis: a long-term follow-up study
Cacoub, P., Si ahmed, S.N., ferfar, Y., Pol, S., Thabut, D., Hezode, C., Alric, L., Comarmond, C., Ragab, G., Quatuccio, L., Hegazy, M., Poynard, T., Resche Rigon, M., Saadoun, D.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Efficacy and safety of sofosbuvir and daclatasvir for 8 weeks in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus Genotype 3 Infection
Hezode, C, Leroy, V, Rosa, I, Roudot-Thoraval, F, Pawlotsky, J.-M, de Ledinghen, V, Bronowicki, J.-P
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients
Boursier, J., Ducancelle, A., Vergniol, J., Veillon, P., Moal, V., Dufour, C., Bronowicki, J.-P., Larrey, D., Hézode, C., Zoulim, F., Fontaine, H., Canva, V., Poynard, T., Allam, S., De Lédinghen, V.
Published in Journal of viral hepatitis (01.12.2015)
Published in Journal of viral hepatitis (01.12.2015)
Get full text
Journal Article
Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection
Sultanik, P.-S., Casrouge, A., Alanio, C., Mottez, E., Rosa-Hézode, I., Hézode, C., Renard, P., Bousquet, L., Pellet, P., Uzé, G., Pol, S., Albert, M. L., Mallet, V.
Published in Journal of viral hepatitis (01.06.2015)
Published in Journal of viral hepatitis (01.06.2015)
Get full text
Journal Article
Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme
Leroy, V, Hézode, C, Métivier, S, Tateo, M, Conti, F, Nguyen-Khac, E, Lacoste, D, Vergniol, J, Truchi, R, Guyader, D, Riachi, G, Michau, C, Blaison, D, Oberti, F, Fontaine, H, Di Martino, V, Bronowicki, J.-P, Akremi, R, Bennai, Y, Filipovics, A, Pageaux, G.-P
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Daclatasvir plus Sofosbuvir plus Ribavirin for 12 or 16 Weeks in Treatment-Experienced Patients with HCV Genotype 3 Infection and Advanced Fibrosis or Cirrhosis
Hezode, C, Dore, G, Pianko, S, Pol, S, Stuart, K, Thompson, A, Tse, E, Bhore, R, Jimenez-Exposito, M.J
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Sofosbuvir plus daclatasvir for hepatitis C virus-cryoglobulinemia vasculitis (HCV-CryoVas): VASCUVALDIC 2 Study
Saadoun, D, Pol, S, Ferfar, Y, Hezode, C, Ahmed, S.N.S, Alric, L, de Saint Martin, L, Bouyer, A.S, Musset, L, Poynard, T, Rigon, M.R, Cacoub, P
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Safety of glecaprevir/pibrentasvir in adults with chronic genotype 1–6 hepatitis C virus infection: an integrated analysis
Dufour, J.-F, Zuckerman, E, Zadeikis, N, Hezode, C, Paik, S.W, Andreone, P, Weiland, O, Slim, J, Flamm, S.L, Morgan, T, Vargas, H, Strasser, S, Brown, A, Yu, Y, Porcalla, A, Mensa, F
Published in JOURNAL OF HEPATOLOGY (2017)
Published in JOURNAL OF HEPATOLOGY (2017)
Get full text
Journal Article
Conference Proceeding
High SVR rates with eight and twelve weeks of pangenotypic glecaprevir/pibrentasvir: integrated efficacy and safety analysis of genotype 1–6 patients without cirrhosis
Puoti, M, Foster, G, Wang, S, Mutimer, D, Gane, E, Moreno, C, Chang, T.T, Lee, S.S, Marinho, R, Dufour, J.-F, Pol, S, Hezode, C, Gordon, S.C, Strasser, S.I, Thuluvath, P.J, Liu, R, Pilot-Matias, T, Mensa, F
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
P0843 : On-treatment viral kinetics do not predict SVR in patients with advanced liver disease receiving sofosbuvir in combination with daclatasvir or simeprevir for 12 weeks
Hezode, C, Chevaliez, S, Scoazec, G, Bouvier-Alias, M, Ruiz, I, Francois, M, Mallat, A, Feray, C, Pawlotsky, J.-M
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
Impact of smoking on histological liver lesions in chronic hepatitis C
Hézode, C, Lonjon, I, Roudot-Thoraval, F, Mavier, J-P, Pawlotsky, J-M, Zafrani, E S, Dhumeaux, D
Published in Gut (01.01.2003)
Published in Gut (01.01.2003)
Get full text
Journal Article
Efficacy and Tolerability of Simeprevir and Daclatasvir for 12 or 24 Weeks in HCV Genotype 1b-Infected Treatment-Naïve Patients with Advanced Fibrosis or Compensated Cirrhosis
Hezode, C, Almasio, P, Bourgeois, S, Buggisch, P, Brown, A, Diago, M, Horsmans, Y, Serfaty, L, Szalay, F, Gaeta, G.B, Planas, R, Schlag, M, Lonjon-Domanec, I, Gilles, L, DeMasi, R, Zeuzem, S
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Retreatment of HCV DAA Failures: HCV Infection may be Incurable
Hezode, C, Fourati, S, Scoazec, G, Soulier, A, Varaut, A, Francois, M, Ruiz, I, Mallat, A, Chevaliez, S, Pawlotsky, J.-M
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Resistance Analysis in 1284 Patients with Genotype 1 to 6 HCV Infection Treated with Sofosbuvir/Velpatasvir in the Phase 3 Astral-1, Astral-2, Astral-3 and Astral-4 Studies
Hezode, C, Reau, N, Svarovskaia, E, Doehle, B.P, Chodavarapu, K, Dvory-Sobol, H, Mcnally, J, Osinusi, A, Brainard, D.M, Miller, M.D, Mo, H, Roberts, S, O’leary, J.G
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Improvement in Markers of Liver Fibrosis and Function in HCV Genotype 4-Infected Patients with Compensated Cirrhosis Receiving Ombitasvir/Paritaprevir/Ritonavir with Ribavirin (AGATE-I)
Hassanein, T.I, Asselah, T, Qaqish, R.B, Hezode, C, Mulkay, J.-P, Moreno, C, ElKhashab, M, Alqahtani, S, Yu, Y, Redman, R, Mobashery, N
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article